BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23

• Press Releases

  AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026

  October 2, 2026

   · 

  3 min read
• Press Releases

  Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients

  October 2, 2026

   · 

  4 min read
• Press Releases

  Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026

  October 2, 2026

   · 

  1 min read
• Press Releases

  CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies

  October 2, 2026

   · 

  4 min read
• Press Releases

  Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 1, 2026

  October 2, 2026

   · 

  2 min read
• Press Releases

  Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair

  October 2, 2026

   · 

  4 min read
• Press Releases

  Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 1, 2026

  October 2, 2026

   · 

  1 min read
• Press Releases

  Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn

  October 2, 2026

   · 

  6 min read
• Press Releases

  Medicenna Announces Results of Annual General and Special Meeting of Shareholders

  October 2, 2026

   · 

  5 min read
• Press Releases

  New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program

  October 2, 2026

   · 

  6 min read